Exhibit 10.1
ACASTI PHARMA INC.
STOCK OPTION PLAN AS AMENDED SEPTEMBER 28, 2022
OPTION AGREEMENT
(the “Option Agreement”)
Acasti Pharma Inc. (the “Company”) hereby grants the following Options to you subject to the terms and conditions of this Option Agreement, together with the provisions of the Company’s Stock Option Plan as amended September 28, 2022 (the “Plan”), all the terms of which Plan are hereby incorporated into this Option Agreement:
Name of Option Holder: ____________________________________________________
Grant Date: _____________________________________________
Number of Options Granted: ________________________________________________
Exercise Price:
Expiry Date:
The Options are intended to be incentive stock options qualifying under Section 422 of the Code, although the Company makes no representation or guarantee that the Options will qualify as ISOs.
- 2 -
|
| ACASTI PHARMA INC.
| |
By: |
| ||
|
| ||
|
|
DOCPROPERTY "DocsID" \* MERGEFORMAT LEGAL_1:71361924.1
- 3 -
VESTING SCHEUDLE TO OPTION AGREEMENT
Vesting Schedule: [ ]
DOCPROPERTY "DocsID" \* MERGEFORMAT LEGAL_1:71361924.1
- 4 -
UNDERSTANDING, ACKNOWLEDGEMENT AND ACCEPTANCE:
I acknowledge that I have received a copy of the Plan. I have read this Option Agreement and the Plan and accept the Options in accordance with and subject to the terms and conditions of this Option Agreement and the Plan.
|
|
|
Date Accepted |
| Signature |
DOCPROPERTY "DocsID" \* MERGEFORMAT LEGAL_1:71361924.1